We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TWTG market cap is 16.68M. The company's latest EPS is USD 0.4590 and P/E is 7.63.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 9.62M | 11.06M |
Operating Income | 1.94M | 1.68M |
Net Income | 2.07M | 2.19M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 10.27M | 12.22M |
Total Liabilities | 3.38M | 2.84M |
Total Equity | 6.89M | 9.37M |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -1.07M | 5.81M |
Investing | -228k | -463k |
Financing | 1.19M | 112k |
Market Cap | 16.68M |
Price to Earnings Ratio | 7.63 |
Price to Sales Ratio | 1.51 |
Price to Cash Ratio | 1.89 |
Price to Book Ratio | 1.78 |
Dividend Yield | - |
Shares Outstanding | 4.77M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | 20 20 GeneSystems Inc (GM) |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.2020gene.com |
Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions